These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 10491011

  • 1. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N, Jacobson S, Leist T, Waldmann TA.
    J Immunol; 1999 Oct 01; 163(7):4064-72. PubMed ID: 10491011
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S.
    J Immunol; 1998 Jul 01; 161(1):482-8. PubMed ID: 9647259
    [Abstract] [Full Text] [Related]

  • 3. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, Waldmann TA.
    J Cell Biochem; 1991 Aug 01; 46(4):302-11. PubMed ID: 1757474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.
    J Infect Dis; 2001 Mar 15; 183(6):857-64. PubMed ID: 11237801
    [Abstract] [Full Text] [Related]

  • 6. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E, Cartier L, Torres M, Barria M.
    J Med Virol; 2007 Jun 15; 79(6):782-90. PubMed ID: 17457906
    [Abstract] [Full Text] [Related]

  • 7. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA, Penalva de Oliveira AC, Smid J, Fukumori LM, Olah I, da S Duarte AJ, Casseb J.
    Scand J Immunol; 2009 Oct 15; 70(4):403-7. PubMed ID: 19751276
    [Abstract] [Full Text] [Related]

  • 8. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
    Santos SB, Porto AF, Muniz AL, Luna T, Nascimento MC, Guerreiro JB, Oliveira-Filho J, Morgan DJ, Carvalho EM.
    Neuroimmunomodulation; 2006 Oct 15; 13(3):145-51. PubMed ID: 17119343
    [Abstract] [Full Text] [Related]

  • 9. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Furukawa K, Mori M, Ohta N, Ikeda H, Shida H, Furukawa K, Shiku H.
    J Clin Invest; 1994 Nov 15; 94(5):1830-9. PubMed ID: 7962528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
    Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S.
    Ann Neurol; 1998 Dec 15; 44(6):942-7. PubMed ID: 9851439
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, Osame M.
    J Infect Dis; 2003 Apr 01; 187(7):1116-25. PubMed ID: 12660926
    [Abstract] [Full Text] [Related]

  • 14. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S.
    J Infect Dis; 2001 Jan 15; 183(2):197-205. PubMed ID: 11120926
    [Abstract] [Full Text] [Related]

  • 15. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ.
    Rev Neurol; 2001 Jan 15; 48(3):147-55. PubMed ID: 19206063
    [Abstract] [Full Text] [Related]

  • 16. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis.
    Marriott SJ, Trinh D, Brady JN.
    Oncogene; 1992 Sep 15; 7(9):1749-55. PubMed ID: 1501887
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Höger TA, Jacobson S, Kawanishi T, Kato T, Nishioka K, Yamamoto K.
    J Immunol; 1997 Aug 15; 159(4):2042-8. PubMed ID: 9257872
    [Abstract] [Full Text] [Related]

  • 18. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
    Alberti C, Cartier L, Valenzuela MA, Puente J, Tanaka Y, Ramirez E.
    J Med Virol; 2011 Sep 15; 83(9):1641-9. PubMed ID: 21739457
    [Abstract] [Full Text] [Related]

  • 19. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
    Daenke S, Kermode AG, Hall SE, Taylor G, Weber J, Nightingale S, Bangham CR.
    Virology; 1996 Mar 01; 217(1):139-46. PubMed ID: 8599198
    [Abstract] [Full Text] [Related]

  • 20. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, Bangham CR, Osame M.
    J Infect Dis; 2004 Oct 01; 190(7):1279-85. PubMed ID: 15346339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.